Advertisement

Topics

Biosimilar Avastin wins EU approval

04:45 EST 22 Jan 2018 | PharmaTimes

European regulators have issued a green light for Amgen and Allergan’s Mvasi, marking the first biosimilar of Roche’s Avastin to be approved in the region.

Original Article: Biosimilar Avastin wins EU approval

NEXT ARTICLE

More From BioPortfolio on "Biosimilar Avastin wins EU approval"

Quick Search
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biosimilars
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...